Phibro Animal Health (NASDAQ:PAHC) Sees Unusually-High Trading Volume - Should You Buy?

Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) saw an uptick in trading volume on Wednesday . 326,135 shares changed hands during trading, an increase of 112% from the previous session's volume of 153,695 shares.The stock last traded at $21.66 and had previously closed at $20.68.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Barclays boosted their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a research report on Tuesday, November 12th. StockNews.com upgraded shares of Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a report on Saturday. Morgan Stanley raised their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a report on Tuesday, December 17th. Finally, JPMorgan Chase & Co. assumed coverage on Phibro Animal Health in a report on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 price objective on the stock. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, Phibro Animal Health has an average rating of "Hold" and a consensus target price of $20.50.

Phibro Animal Health Trading Up 3.9 %

The company's 50 day simple moving average is $22.89 and its two-hundred day simple moving average is $21.06. The company has a market cap of $870.00 million, a PE ratio of 49.95, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were issued a $0.12 dividend. The ex-dividend date was Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.23%. Phibro Animal Health's dividend payout ratio (DPR) is presently 111.63%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Sofinnova Investments Inc. acquired a new position in shares of Phibro Animal Health in the second quarter valued at approximately $3,975,000. Geode Capital Management LLC grew its stake in shares of Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after acquiring an additional 27,201 shares in the last quarter. Barclays PLC increased its position in shares of Phibro Animal Health by 25.7% during the third quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after acquiring an additional 29,271 shares during the period. Acadian Asset Management LLC raised its stake in shares of Phibro Animal Health by 6.3% in the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company's stock valued at $12,027,000 after acquiring an additional 42,299 shares in the last quarter. Finally, Algert Global LLC boosted its holdings in Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company's stock valued at $1,606,000 after purchasing an additional 59,850 shares during the period. 99.34% of the stock is currently owned by institutional investors and hedge funds.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.